Scientist Solutions: International Life Science Community By Scientists For Scientists

Thanks to our sponsors who make this site possible

    

Scientist-Solutions

 



Google+

At Scientist Solutions we cherish our role as a trusted source of information for scientists.  We hope that our newly designed site will make it easier than ever for you to access everything we have to offer.   Things may have moved around a little, but rest assured that all the features you enjoyed on our old site (the forums, the protocols, the events, my bench space, blogs)  are still here.  

Our Discussion Forums

Scientist Solutions began as a discussion board for life scientists and that is still one of our core offerings.   If you are looking for the discussion forums, please click "The Forums"  from the navigation bar above or click here.

Protocols and SciEvents

Always on the look out for new ways to help scientists to help each other,  Scientist Solutions introduced a new protocols section and an events section to our site in the past year.   Both have been very popular.   If you haven't yet discovered these listings, we invite you to do so now. 

Our Protocol Finder provides an easily searchable database of protocols that you can use both to find a protocol you need or to share the protocols that you rely on.  Just click "Protocol Finder" from the navigation bar above, or click here.

Our SciEvents section is setting out to be the most comprehensive listing of conferences, seminars, classes and webinars for life scientists on the web.   Search events listings by date, topic or type of event.    You are most welcome to add your own events to our listing too.   Just click SciEvents from the navigation bar above, or click here.

My Bench SpaceMembership Management

Are you looking for how to log in or wondering what happened to your bench space?     On our new site, we have made it much easier for you to manage your account and profile.   After logging in (note that the log in area has moved down the page),  you will see your new member status panel on the right hand side of the home page and every page.    Look here for an overview of your member information and find easy access to your newly remodeled My Bench Space, where you'll be able to edit your account information and preferences and manage your public profile.   Just click "Go to My Bench Space" from your member status panel or click here.

Blogging

Notice that featured blogs are now presented on the home page just below this article.   To read all blogs, just click the "view more" link below the featured blogs.   To create your own blog, go to your My Bench Space pages and click on the "blogs" tab.  To get to My Bench Space, log in then click the "Go to My Bench Space" link in your member status panel (see above) or just click here

Give us your feedback

We understand that it takes a little adjustment time to get used to a new design.  We apologize for any temporary confusion, but hope that once you've familiarized yourself with the new design and features you will be very pleased.   Either way, we would love to hear what you think.  Please share your opinion by clicking the 'contact us'  link at the top right of any page and send us a note or click here.




Latest Member Blogs

Member
Total Posts: 1
6/14/2017
09:29PM
Member
Total Posts: 1
6/14/2017
02:18PM
Member
Total Posts: 1
6/13/2017
09:49AM




Science News Feeds

Click a source to select it and see feeds below

BioScience News
Pharmaceutical News
Biotechnology News
Today's Science News
This Week in Science
Science (Editorial)
Science Now
Nextwave
New York Times
BBC
Bioscreening
Journals
Journal of Biology
Nature
European Journal of Cell Biology
Virology Journal
Science
PNAS
Magazines
New Scientist
The Scientist
Pharmaceutical Business Review
Life Sciences World
Science News

Biotechnology - Google News
Google News
This RSS feed URL is deprecated
This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news
Pounding the Pavement on Shares of Biotechnology Index NYSE ETF (FBT) - TCT

Pounding the Pavement on Shares of Biotechnology Index NYSE ETF (FBT)
TCT
Biotechnology Index NYSE ETF (FBT) shares are on chartist's watch as the stock is edging above the MACD Histogram zero line. Current levels place the share price around 121.64, while the MACD indicates a bullish trend. The MACD-Histogram is an ...

and more »
Heron Therapeutics, Inc. (NASDAQ:HRTX) Stock Rating Reaffirmed by Cantor Fitzgerald - StockNewsTimes

Heron Therapeutics, Inc. (NASDAQ:HRTX) Stock Rating Reaffirmed by Cantor Fitzgerald
StockNewsTimes
Heron Therapeutics logo Heron Therapeutics, Inc. (NASDAQ:HRTX)'s stock had its “buy” rating reaffirmed by Cantor Fitzgerald in a note issued to investors on Thursday, November 2nd. They currently have a $31.00 target price on the biotechnology ...

and more »
Celator Pharmaceuticals (CPXX) versus The Competition Financial Comparison - Week Herald

Celator Pharmaceuticals (CPXX) versus The Competition Financial Comparison
Week Herald
Celator Pharmaceuticals (NASDAQ: CPXX) is one of 187 publicly-traded companies in the “Biotechnology & Medical Research” industry, but how does it weigh in compared to its competitors? We will compare Celator Pharmaceuticals to related companies ...

Global NBQX Disodium Salt Market 2017 R&D Systems, Abcam, Stemgent, Cayman Chemical, Santa Cruz ... - ExpressObserver

ExpressObserver

Global NBQX Disodium Salt Market 2017 R&D Systems, Abcam, Stemgent, Cayman Chemical, Santa Cruz ...
ExpressObserver
NBQX Disodium Salt Market Global NBQX Disodium Salt Market 2017 presents a widespread and elementary study of NBQX Disodium Salt business at the side of the analysis of subjective aspects which is able to give key business insights to the readers.

Global Metformin Hydrochloride Market 2017 R&D Systems, Abcam, Stemgent, Cayman Chemical, Santa Cruz ... - ExpressObserver

ExpressObserver

Global Metformin Hydrochloride Market 2017 R&D Systems, Abcam, Stemgent, Cayman Chemical, Santa Cruz ...
ExpressObserver
Metformin Hydrochloride Market Global Metformin Hydrochloride Market 2017 presents a widespread and elementary study of Metformin Hydrochloride business at the side of the analysis of subjective aspects which is able to give key business insights to ...

Wedbush Reaffirms “Outperform” Rating for bluebird bio, Inc. (BLUE) - The Ledger Gazette

Wedbush Reaffirms “Outperform” Rating for bluebird bio, Inc. (BLUE)
The Ledger Gazette
bluebird bio, Inc. logo Wedbush restated their outperform rating on shares of bluebird bio, Inc. (NASDAQ:BLUE) in a research note published on Thursday, November 2nd, The Fly reports. They currently have a $174.00 price objective on the biotechnology ...

and more »
Conatus Pharmaceuticals Inc. (CNAT) Rating Reiterated by HC Wainwright - Week Herald

Conatus Pharmaceuticals Inc. (CNAT) Rating Reiterated by HC Wainwright
Week Herald
Conatus Pharmaceuticals Inc. (NASDAQ:CNAT)'s stock had its “buy” rating reaffirmed by stock analysts at HC Wainwright in a report released on Thursday, November 2nd, MarketBeat reports. They currently have a $17.00 price objective on the biotechnology ...

and more »
HC Wainwright Increases Cidara Therapeutics, Inc. (CDTX) Price Target to $16.00 - Week Herald

HC Wainwright Increases Cidara Therapeutics, Inc. (CDTX) Price Target to $16.00
Week Herald
Cidara Therapeutics, Inc. logo Cidara Therapeutics, Inc. (NASDAQ:CDTX) had its price target upped by HC Wainwright from $14.00 to $16.00 in a research note published on Thursday, November 9th. They currently have a buy rating on the biotechnology ...

and more »
Prima BioMed Ltd (PBMD) Receives “Buy” Rating from Maxim Group - Week Herald

Prima BioMed Ltd (PBMD) Receives “Buy” Rating from Maxim Group
Week Herald
Prima BioMed logo Prima BioMed Ltd (NASDAQ:PBMD)'s stock had its “buy” rating reiterated by stock analysts at Maxim Group in a research note issued to investors on Thursday, November 9th. They presently have a $7.00 target price on the biotechnology ...

and more »
bluebird bio, Inc. (NASDAQ:BLUE) Shares Bought by Tocqueville Asset Management LP - StockNewsTimes

bluebird bio, Inc. (NASDAQ:BLUE) Shares Bought by Tocqueville Asset Management LP
StockNewsTimes
The firm owned 55,690 shares of the biotechnology company's stock after purchasing an additional 24,400 shares during the quarter. Tocqueville Asset Management L.P. owned approximately 0.12% of bluebird bio worth $7,649,000 as of its most recent SEC ...

and more »